Finally, consistent with DS‐GPA and SEER data, triple‐negative breast cancer remained the breast‐cancer subtype with the shortest OS among brain‐metastasis patients, underscoring the lack of effective targeted treatments relative to hormone‐receptor‐ or HER2‐positive tumours [1, 2]. The gene discussed is ERBB2; the disease is neoplasm.